NANORX INC has a total of 23 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, machines and micro-structure and nano-technology are VELA PHARMACEUTICALS INC, FUMAPHARM AG and DEPRENYL ANIMAL HEALTH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Argentina | 1 | |
#7 | Chile | 1 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | Russian Federation | 1 | |
#13 | Singapore | 1 | |
#14 | Taiwan | 1 | |
#15 | United States | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Micro-structure and nano-technology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Raghavan Palayakotai R | 20 |
#2 | Palayakotai R Raghavan | 2 |
Publication | Filing date | Title |
---|---|---|
US2014275285A1 | Metadichol® liquid and gel nanoparticle formulations | |
CA2844073A1 | Policosanol nanoparticles | |
CA2788777A1 | Policosanol nanoparticles |